Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Asset Utilization Ratio of 0.59 for Q2 2026, down 1.94% on a QoQ basis from 0.6 in Q1 2026, and down 11.6% year-over-year from 0.67 in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.59 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 11.6% year-over-year to 0.59 in Q2 2026; TTM through Jun 2026 was 0.59, a 11.6% decrease from a year earlier, with the FY2026 full-year figure at 0.6, down 18.92% from the prior year.
- Asset Utilization Ratio was 0.59 for Q2 2026 at Dr Reddys Laboratories, down from 0.6 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.81 in Q2 2023, with the low at 0.59 in Q2 2026.
- Average Asset Utilization Ratio over 5 years is 0.71, with a median of 0.72 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio advanced 10.91% in 2023, then declined 14.14% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.81 in 2022, then decreased by 4.58% to 0.77 in 2023, then slipped by 14.14% to 0.66 in 2024, then fell by 4.12% to 0.63 in 2025, then declined by 6.81% to 0.59 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.59 (Q2 2026), 0.6 (Q1 2026), and 0.63 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 0.44 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 0.23 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 0.67 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | 0.73 |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.59 |
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.63 |
| Sep 30, 2025 | 0.65 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 0.68 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.74 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.78 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.80 |
| Dec 31, 2022 | 0.81 |
| Sep 30, 2022 | 0.79 |
| Jun 30, 2022 | 0.73 |
| Mar 31, 2022 | 0.76 |
| Dec 31, 2021 | 0.76 |
| Sep 30, 2021 | 0.74 |